Bryan M. Webb

Bryan M. Webb

Auto-generated profile, based on publicly available information

Bryan M. Webb

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA; Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KPKatrina M. Piemonte
Katrina M. Piemonte
BWBryan M. Webb
Bryan M. Webb
JBJessica R. Bobbitt
Jessica R. Bobbitt
PMParth R. Majmudar
Parth R. Majmudar
LCLeslie Cuellar-Vite
Leslie Cuellar-Vite
RKRuth Keri
Ruth Keri
Chromatin organization is highly dynamic and modulates DNA replication, transcription, and chromosome segregation. Condensin is essential for chromosome assembly during mitosis and meiosis, as well as maintenance of chromosome structure during interphase. While it is well established that sustained condensin expression is necessary to ensure chromosome stability, the mechanisms that control its expression are not yet known. Herein, we report that disruption of cyclin-dependent kinase 7 (CDK7), the core catalytic subunit of CDK-activating kinase, leads to reduced transcription of several condensin subunits, including structural maintenance of chromosomes 2 (SMC2). Live and static microscopy revealed that inhibiting CDK7 signaling prolongs mitosis and induces chromatin bridge formation, DNA double-strand breaks, and abnormal nuclear features, all of which are indicative of mitotic catastrophe and chromosome instability. Affirming the importance of condensin regulation by CDK7, genetic suppression of the expression of SMC2, a core subunit of this complex, phenocopies CDK7 inhibition. Moreover, analysis of genome-wide chromatin conformation using Hi-C revealed that sustained activity of CDK7 is necessary to maintain chromatin sublooping, a function that is ascribed to condensin. Notably, the regulation of condensin subunit gene expression is independent of superenhancers. Together, these studies reveal a new role for CDK7 in sustaining chromatin configuration by ensuring the expression of condensin genes, including SMC2.

25 January 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
LALindsey J. Anstine
Lindsey J. Anstine
PMParth R. Majmudar
Parth R. Majmudar
AAAmy Aponte
Amy Aponte
Salendra SinghSalendra Singh
Salendra Singh
RZRan Zhao
Ran Zhao
RKRuth Keri
Ruth Keri
Breast cancer subtypes and their phenotypes parallel different stages of the mammary epithelial cell developmental hierarchy. Discovering mechanisms that control lineage identity could provide novel avenues for mitigating disease progression. Here we report that the transcriptional corepressor TLE3 is a guardian of luminal cell fate in breast cancer and operates independently of the estrogen receptor. In luminal breast cancer, TLE3 actively repressed the gene-expression signature associated with highly aggressive basal-like breast cancers (BLBC). Moreover, maintenance of the luminal lineage depended on the appropriate localization of TLE3 to its transcriptional targets, a process mediated by interactions with FOXA1. By repressing genes that drive BLBC phenotypes, including SOX9 and TGFβ2, TLE3 prevented the acquisition of a hybrid epithelial–mesenchymal state and reduced metastatic capacity and aggressive cellular behaviors. These results establish TLE3 as an essential transcriptional repressor that sustains the more differentiated and less metastatic nature of luminal breast cancers. Approaches to induce TLE3 expression could promote the acquisition of less aggressive, more treatable disease states to extend patient survival. Significance: Transcriptional corepressor TLE3 actively suppresses SOX9 and TGFβ transcriptional programs to sustain the luminal lineage identity of breast cancer cells and to inhibit metastatic progression.

4 April 2023
Verified
Other
Open access
LALindsey J. Anstine
Lindsey J. Anstine
PMParth R. Majmudar
Parth R. Majmudar
AAAmy Aponte
Amy Aponte
Salendra SinghSalendra Singh
Salendra Singh
RZRan Zhao
Ran Zhao
RKRuth Keri
Ruth Keri



4 April 2023
Verified
Other
Open access
LALindsey J. Anstine
Lindsey J. Anstine
PMParth R. Majmudar
Parth R. Majmudar
AAAmy Aponte
Amy Aponte
Salendra SinghSalendra Singh
Salendra Singh
RZRan Zhao
Ran Zhao
RKRuth Keri
Ruth Keri